Da-Tong Ju

Dr. Da-Tong Ju


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
DJDa-Tong Ju
Da-Tong Ju
AKAshok Kumar K.
Ashok Kumar K.
WKWei Wen Kuo
Wei Wen Kuo
THTsung-Jung Ho
Tsung-Jung Ho
RCRuey-Lin Chang
Ruey-Lin Chang
CHChih-Yang Huang
Chih-Yang Huang
Hypertension is one of the growing risk factors for the progression of long-term memory loss. Hypertension-mediated memory loss and treatment remain not thoroughly elucidated to date. Plant-based natural compounds are an alternative solution to treating human diseases without side effects associated with commercial drugs. This study reveals that bioactive peptides extracted from soy hydrolysates mimic hypertension-mediated memory loss and neuronal degeneration and alters the memory molecular pathway in spontaneously hypertensive rats (SHR). The SHR animal model was treated with bioactive peptide VHVV (10 mg/kg/oral administration) and angiotensin-converting-enzyme (ACE) inhibitors (5 mg/kg/oral administration) for 24 weeks. We evaluated molecular level expression of brain-derived neurotrophic factor (BDNF), cAMP response element binding protein (CREB), and survival markers phospho-protein kinase B (P-AKT) and phosphoinositide 3-kinase (PI3K) after 24 weeks of treatment for SHR in this study. Western blotting, hematoxylin and eosin (H&E) staining, and immunohistochemistry showed long-term memory loss and neuronal degeneration in SHR animals. Bioactive peptide VHVV-treated animals upregulated the expression of long-term memory-relate proteins and neuronal survival. Spontaneously hypertensive rats treated with oral administration of bioactive peptide VHVV had activated CREB-mediated downstream proteins which may reduce hypertension-mediated long-term memory loss and maintain neuronal survival.

7 June 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
CHChih-Yang Huang
Chih-Yang Huang
KSKalaiselvi Sivalingam
Kalaiselvi Sivalingam
SAShibu Marthandam Asokan
Shibu Marthandam Asokan
PLPo-Hsiang Liao
Po-Hsiang Liao
THTsung-Jung Ho
Tsung-Jung Ho
DJDa-Tong Ju
Da-Tong Ju
Mitochondrial dysfunction and disturbed mitochondrial dynamics were found to be common phenomena in the pathogenesis of Parkinson’s disease (PD). Vasicinone is a quinazoline alkaloid from Adhatoda vasica. Here, we investigated the autophagy/mitophagy-enhancing effect of vasicinone and explored its neuroprotective mechanism in paraquat-mimic PD modal in SH-SY5Y cells. Vasicinone rescued the paraquat-induced loss of cell viability and mitochondrial membrane potential. Subsequently, the accumulation of mitochondrial reactive oxygen species (ROS) was balanced by an increase in the expression of antioxidant enzymes. Furthermore, vasicinone restored paraquat-impaired autophagy and mitophagy regulators DJ-1, PINK-1 and Parkin in SH-SY5Y cells. The vasicinone mediated autophagy pathways were abrogated by treatment with the autophagy inhibitor 3-MA, which lead to increases α-synuclein accumulation and decreased the expression of p-ULK and ATG proteins and the autophagy marker LC3-II compared to that observed without 3-MA treatment. These results demonstrated that vasicinone exerted neuroprotective effects by upregulating autophagy and PINK-1/Parkin mediated mitophagy in SH-SY5Y cells.

19 July 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
DJDa-Tong Ju
Da-Tong Ju
KSKalaiselvi Sivalingam
Kalaiselvi Sivalingam
WKWei Wen Kuo
Wei Wen Kuo
THTsung-Jung Ho
Tsung-Jung Ho
RCRuey-Lin Chang
Ruey-Lin Chang
CHChih-Yang Huang
Chih-Yang Huang
Vasicinone is a quinazoline alkaloid isolated from the Adhatoda vasica plant. In this study, we explored the neuroprotective effect and underlying molecular mechanism of vasicinone against paraquat-induced cellular apoptosis in SH-SY5Y cells. Vasicinone reduced the paraquat-induced loss of cell viability, rescued terminal deoxynucleotide transferase-mediated dUTP nick end-labeling (TUNEL)-positive apoptotic nuclei, and suppressed generation of reactive oxygen species (ROS) in a dose-dependent manner. Western blotting analysis revealed that vasicinone increased the phosphorylation of IGF1R/PI3K/AKT cell survival signaling molecules and downregulated the paraquat-induced, mitogen-activated protein kinase (MAPK)/c-Jun N-terminal kinase (JNK)-mediated apoptotic pathways compared to that observed in cells not treated with vasicinone. This protection depended critically on the activation of IGF1R, and the silencing of IGF1R by siRNA completely abrogated the protective effect of vasicinone in SH-SY5Y cells. Our findings indicated that vasicinone is a potential candidate for the treatment of Parkinson’s disease and possibly other oxidative stress-related neurodegenerative disorders.

29 April 2010 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
KTKuan-Yin Tseng
Kuan-Yin Tseng
MCMin-Huey Chung
Min-Huey Chung
HSHuey-Kang Sytwu
Huey-Kang Sytwu
HLHorng-Mo Lee
Horng-Mo Lee
KCKuan-Yu Chen
Kuan-Yu Chen
Dueng-Yuan HuengDueng-Yuan Hueng
Dueng-Yuan Hueng

Verified
Journal Article
Open access
PDF file
CYCheng-Hsun Yang
Cheng-Hsun Yang
WTWei-Jen Ting
Wei-Jen Ting
CDCecilia Hsuan Day
Cecilia Hsuan Day
DJDa-Tong Ju
Da-Tong Ju
YYYu-Lan Yeh
Yu-Lan Yeh
CHChih-Yang Huang
Chih-Yang Huang
Patients with liver cirrhosis also have subtle cardiac structure or function abnormalities. This cardiac dysfunction commonly occurs in 56% of waiting orthotopic liver transplantation (OLT) patients and is defined as cirrhotic cardiomyopathy (CCM). Up to now, there is no standard treatment because CCM does not have a solidly established diagnosis and is based on high clinical suspicion. The liver function of CCM is particularly limited, making patients vulnerable to more drug treatments. Here, we use silymarin (100 mg/kg/day), baicalein (30 mg/kg/day), San Huang Shel Shin Tang (SHSST, 30 mg/kg/day) and β-cyclodextrin modified SHSST (SHSSTc, 30 and 300 mg/kg/day) treatments for a CCl4-induced CCM rat model. The results show that silymarin, baicalein and SHSST treatments can only slightly reduce the collagen accumulation in CCM rat hearts. However, SHSSTc treatment protects the heart in CCM and significantly inhibits collagen acumination and the fibrosis regulating transforming growth factor-β (TGF-β) pathway expression. SHSSTc treatments further reduced the heart weight and the ratio between left ventricular weight (LVW) and tibia length (TL). This experimental data show that water solubility improved β-cyclodextrin modified Chinese herbal medicine formula (SHSSTc) can provide an excellent heart protection effect through TGF-β pathway inhibition.

13 July 2022 in Neurotoxicity Research
Verified
Journal Article
Closed access
PDF file
MCMing-Shan Chen
Ming-Shan Chen
BTBruce Chi-Kang Tsai
Bruce Chi-Kang Tsai
MSMaria Angelina Sitorus
Maria Angelina Sitorus
CKChia-Hua Kuo
Chia-Hua Kuo
WKWei-Wen Kuo
Wei-Wen Kuo
DJDa-Tong Ju
Da-Tong Ju